P Neilson
Women's Health · Davenport, IANPI 1255305082
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Astellas Pharma US Inc at 27.1% of the total. Reporting peaked in 2023 at $849 and has fallen 73.5% since, to $225 in 2025. Among women's health clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $27.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$682
- AbbVie$496
- Avion Pharmaceuticals$220
- Bayer$187
- Acella Pharmaceuticals, LLC$130
- Exeltis, USA Inc.$103
- plus $700 from 17 others
What the payments were for
- Food & beverage$2,50399%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 14 | $682 |
| AbbVie | 21 | $496 |
| Avion Pharmaceuticals | 1 | $220 |
| Bayer | 8 | $187 |
| Acella Pharmaceuticals, LLC | 1 | $130 |
| Exeltis, USA Inc. | 6 | $103 |
| Coopersurgical, Inc. | 6 | $92 |
| Organon | 6 | $89 |
| Biogen | 5 | $88 |
| Myovant Sciences Inc. | 3 | $59 |
| Hologic Sales And Service, LLC | 3 | $58 |
| Axonics, Inc. | 2 | $55 |
| Novo Nordisk | 3 | $53 |
| Pfizer | 2 | $40 |
| Merck | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Exact Sciences | 1 | $17 |
| Vertex | 1 | $17 |
| Medline Industries LP | 1 | $15 |
| Medtronic | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$490
- DIVIGEL$220
- NP Thyroid 60$130
- UBRELVY$102
How this compares
$2,519 in reported general payments places this provider in the 90th percentile of 58 women's health providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 85 | $4,253 |
| ProgesteroneProgesterone, Micronized | 51 | $1,699 |
| Ibandronate Sodium | 20 | $658 |
| ValacyclovirValacyclovir Hcl | 11 | $417 |
| Clobetasol Propionate | 17 | $313 |
| Alendronate Sodium | 27 | $209 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $146 |
| Levothyroxine Sodium | 19 | $129 |
| Sertraline Hcl | 12 | $54 |
| Alprazolam | 14 | $51 |
Paid to pharmacies, not to this prescriber.
Other women's health in Davenport
- Tami SheldonDavenport$8K
- Susan SchaferDavenport$4K
- Chelsea BenoDavenport$260
- Gayle WallaceDavenport$61
- Darci LewisDes Moines$17K
- Stacy PohlmanCoralville$4K
- Marissa HuettmanBettendorf$3K
- Amy StegerCedar Rapids$2K
- Brandy MitchellIowa City$2K
- Ashley BehymerBettendorf$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.